We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+9.7%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$27.3B
AUM Growth
+$2.26B
Cap. Flow
+$202M
Cap. Flow %
0.74%
Top 10 Hldgs %
24.36%
Holding
1,897
New
97
Increased
682
Reduced
737
Closed
88

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$28.3M
2
ALL icon
Allstate
ALL
+$25.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$19.6M
4
NEOG icon
Neogen
NEOG
+$17.4M
5
DV icon
DoubleVerify
DV
+$17.3M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$29.1M
2
PLNT icon
Planet Fitness
PLNT
+$20.4M
3
ABNB icon
Airbnb
ABNB
+$17.1M
4
IBM icon
IBM
IBM
+$14.8M
5
XMTR icon
Xometry
XMTR
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 25.59%
2 Healthcare 18.44%
3 Industrials 11.64%
4 Financials 11.51%
5 Consumer Discretionary 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNS icon
751
Cadence Design Systems
CDNS
$89.2B
$1.36M 0.01%
5,790
+560
+11% +$122K
AVY icon
752
Avery Dennison
AVY
$13.6B
$1.35M 0.01%
7,878
+3
+0% +$513
MGV icon
753
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.7B
$1.35M ﹤0.01%
13,010
+1,404
+12% +$143K
NBIX icon
754
Neurocrine Biosciences
NBIX
$15.3B
$1.35M ﹤0.01%
14,265
-297,485
-95% -$29.1M
GSK icon
755
GSK
GSK
$101B
$1.34M ﹤0.01%
37,738
+388
+1% +$13.9K
IFF icon
756
International Flavors & Fragrances
IFF
$21.4B
$1.34M ﹤0.01%
16,885
-17,689
-51% -$1.52M
HPQ icon
757
HP
HPQ
$28.6B
$1.34M ﹤0.01%
43,599
-2,230
-5% -$66.9K
HIMS icon
758
Hims & Hers Health
HIMS
$6.71B
$1.34M ﹤0.01%
142,381
-6,667
-4% -$66.1K
LQD icon
759
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$1.32M ﹤0.01%
12,203
-577
-5% -$62.4K
RPM icon
760
RPM International
RPM
$14.5B
$1.31M ﹤0.01%
14,610
-1,054
-7% -$86.6K
HYMB icon
761
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.37B
$1.31M ﹤0.01%
52,245
+715
+1% +$17.8K
RIVN icon
762
Rivian
RIVN
$22.9B
$1.29M ﹤0.01%
77,703
-1,125
-1% -$15.7K
AFL icon
763
Aflac
AFL
$60.7B
$1.29M ﹤0.01%
18,500
+1,923
+12% +$129K
ESGU icon
764
iShares ESG Aware MSCI USA ETF
ESGU
$18.5B
$1.29M ﹤0.01%
13,204
+362
+3% +$33.4K
REGN icon
765
Regeneron Pharmaceuticals
REGN
$83B
$1.28M ﹤0.01%
1,785
-183
-9% -$141K
CNNE icon
766
Cannae Holdings
CNNE
$675M
$1.28M ﹤0.01%
63,435
-14,885
-19% -$286K
XIFR
767
XPLR Infrastructure LP
XIFR
$1.09B
$1.28M ﹤0.01%
21,756
+467
+2% +$28.1K
SCHO icon
768
Schwab Short-Term US Treasury ETF
SCHO
$13B
$1.27M ﹤0.01%
52,946
+8,568
+19% +$208K
OTIS icon
769
Otis Worldwide
OTIS
$27.8B
$1.27M ﹤0.01%
14,293
+2,867
+25% +$242K
SSTI icon
770
SoundThinking
SSTI
$107M
$1.27M ﹤0.01%
58,110
-1,066
-2% -$27.9K
X
771
DELISTED
US Steel
X
$1.26M ﹤0.01%
50,469
-165
-0.3% -$3.84K
EWC icon
772
iShares MSCI Canada ETF
EWC
$6.55B
$1.26M ﹤0.01%
36,073
-579
-2% -$20.1K
SMWB icon
773
Similarweb
SMWB
$789M
$1.26M ﹤0.01%
191,800
-48,544
-20% -$295K
GSIE icon
774
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
$1.25M ﹤0.01%
39,903
+34,745
+674% +$1.09M
DTD icon
775
WisdomTree US Total Dividend Fund
DTD
$1.7B
$1.25M ﹤0.01%
20,146

Similar funds

William Blair & Company's Q2 2023 Portfolio in Review

As of Q2 2023, William Blair & Company held 1,897 positions worth $27.3B, up 9% from $25B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

William Blair & Company's Q2 2023 filing shows 97 new, 682 increased, 737 reduced and 88 closed positions. Its largest new stake was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M. The largest sale was Neurocrine Biosciences, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

  • William Blair & Company's largest Q2 2023 buy was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M.
  • William Blair & Company added most to Costco in Q2 2023, an estimated $28.3M increase.
  • William Blair & Company's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $29.1M.
  • William Blair & Company fully exited ABB Ltd in Q2 2023, selling an estimated $7.21M.
  • William Blair & Company's ten largest holdings make up 24% of its $27.3B portfolio in Q2 2023.
  • William Blair & Company opened 97 new positions and closed 88 in Q2 2023.
  • William Blair & Company's portfolio value rose 9% quarter-over-quarter to $27.3B.

Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.